6
Total investments
3
Early stage
1
Mid stage
2
Late stage
6y
Years active
Portfolio
6 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member & Investor
Jan 2024
At Weave Bio, we’re building the backbone for modern drug development. Drug development teams deserve tools that match the pace and complexity of their science. Our AI-native platform supports biotech and pharma organizations at every step, with a focus on regulatory workflows that bring clarity, connection, and efficiency to documentation so therapies can move forward without unnecessary delays.
We partner with scientists, clinicians, and regulatory professionals who are advancing the next generation of medicines. By improving the processes behind regulatory documentation, Weave helps reduce bottlenecks and frees teams to focus on what matters most — discovery, innovation, and patient impact.
Our approach is human-driven and technology-powered. We believe that combining scientific expertise with AI innovation can transform how life sciences organizations operate, making the development of therapies more efficient, compliant, and collaborative.
Weave is a small but mighty team of scientists, engineers, and industry experts united by a shared mission: helping life-changing medicines reach patients faster. Our collective experience across biotechnology, software, and regulation gives us deep insight into the challenges of drug development — and the passion to build solutions that make a lasting impact.
We’re proud to work side by side with our partners to move science forward and build the foundation that drug development teams need today and tomorrow.
Board Member
Jul 2023
At Terrain Bio, we help RNA therapeutics companies design and build better RNA, faster. Leveraging the latest innovations in protein and RNA design and the deep expertise of its scientific cofounders, we bring unparalleled speed and quality to RNA manufacturing.
Board Member
Jul 2021
We are an end-to-end biotech developing transformational medicines, with technology at our core.
Our ambition is to understand human biology in an unprecedented way; discovering therapies that will treat some of lifes most devastating diseases. We leverage single-cell and multi-omics measurements directly from patient tissue, functional assays and machine learning to drive disease understanding — from cause to cure.
Medicines born from high-resolution biology, machine learning and clinical insights.
Our Lab-in-the-Loop seamlessly integrates single-cell analysis, genomics and machine learning. We have developed powerful technologies which we apply to select druggable targets and develop transformational medicines.
Board Member
Nov 2020
SameSky Health, part of GroundGame.Health, is a cultural experience company that removes barriers to care and forms meaningful relationships to bring people to health. We guide health plan members on their annual wellness journeys by building trusted relationships that encourage dignity, autonomy and companionship as they navigate disparate life experiences within a complex healthcare system.
Launched in 2017, SameSky Health engages 2.3 million+ members across 15 states, in 25+ different languages. The company’s cultural expertise and technology-based solutions enable health plans to grow member engagement, improve quality measures and increase overall health outcomes. We are on a mission to create cultural connections for a healthier, more equitable world. SameSky Health is based in North Hollywood, CA. To learn more, visit www.sameskyhealth.com.
Board Member
Jun 2020
Amydis is leading the way for early detection of diseases through the eye that is accessible, affordable and non-invasive. The company is developing proprietary ocular tracers that enable identification of molecular biomarkers for diseases of the eye, heart and brain. Amydis is creating a data warehouse for multi-omics that includes unique molecular biomarkers of the eye to empower AI-enabled health insights. The Company’s digital health solutions leverage the eye as the “window to the body” to accelerate diagnoses, enable precision treatment and improve patient outcomes.
Experience · 9 entries
All (9)
Investments (6)
Founder (2)
Board (6)
2026
2024
Board Member & Investor
Jan 2024
At Weave Bio, we’re building the backbone for modern drug development. Drug development teams deserve tools that match the pace and complexity of their science. Our AI-native platform supports biotech and pharma organizations at every step, with a focus on regulatory workflows that bring clarity, connection, and efficiency to documentation so therapies can move forward without unnecessary delays.
We partner with scientists, clinicians, and regulatory professionals who are advancing the next generation of medicines. By improving the processes behind regulatory documentation, Weave helps reduce bottlenecks and frees teams to focus on what matters most — discovery, innovation, and patient impact.
Our approach is human-driven and technology-powered. We believe that combining scientific expertise with AI innovation can transform how life sciences organizations operate, making the development of therapies more efficient, compliant, and collaborative.
Weave is a small but mighty team of scientists, engineers, and industry experts united by a shared mission: helping life-changing medicines reach patients faster. Our collective experience across biotechnology, software, and regulation gives us deep insight into the challenges of drug development — and the passion to build solutions that make a lasting impact.
We’re proud to work side by side with our partners to move science forward and build the foundation that drug development teams need today and tomorrow.
2023
Board Member
Jul 2023
At Terrain Bio, we help RNA therapeutics companies design and build better RNA, faster. Leveraging the latest innovations in protein and RNA design and the deep expertise of its scientific cofounders, we bring unparalleled speed and quality to RNA manufacturing.
2021
Board Member
Jul 2021
We are an end-to-end biotech developing transformational medicines, with technology at our core.
Our ambition is to understand human biology in an unprecedented way; discovering therapies that will treat some of lifes most devastating diseases. We leverage single-cell and multi-omics measurements directly from patient tissue, functional assays and machine learning to drive disease understanding — from cause to cure.
Medicines born from high-resolution biology, machine learning and clinical insights.
Our Lab-in-the-Loop seamlessly integrates single-cell analysis, genomics and machine learning. We have developed powerful technologies which we apply to select druggable targets and develop transformational medicines.
2020
Board Member
Nov 2020
SameSky Health, part of GroundGame.Health, is a cultural experience company that removes barriers to care and forms meaningful relationships to bring people to health. We guide health plan members on their annual wellness journeys by building trusted relationships that encourage dignity, autonomy and companionship as they navigate disparate life experiences within a complex healthcare system.
Launched in 2017, SameSky Health engages 2.3 million+ members across 15 states, in 25+ different languages. The company’s cultural expertise and technology-based solutions enable health plans to grow member engagement, improve quality measures and increase overall health outcomes. We are on a mission to create cultural connections for a healthier, more equitable world. SameSky Health is based in North Hollywood, CA. To learn more, visit www.sameskyhealth.com.
Show all 9 entries ↓
Investment activity
2020–2026 · 6 investments
Recent (last 2 years)Earlier
